264 related articles for article (PubMed ID: 22232435)
1. Mesenchymal stem cells induce functionally active T-regulatory lymphocytes in a paracrine fashion and ameliorate experimental autoimmune uveitis.
Tasso R; Ilengo C; Quarto R; Cancedda R; Caspi RR; Pennesi G
Invest Ophthalmol Vis Sci; 2012 Feb; 53(2):786-93. PubMed ID: 22232435
[TBL] [Abstract][Full Text] [Related]
2. Induction of antigen-specific Treg cells in treating autoimmune uveitis via bystander suppressive pathways without compromising anti-tumor immunity.
Chen Z; Zhang T; Kam HT; Qiao D; Jin W; Zhong Y; Zhou M; Zhou H; Chong WP; Chen W; Chen J
EBioMedicine; 2021 Aug; 70():103496. PubMed ID: 34280776
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stem cells ameliorate experimental autoimmune uveoretinitis by comprehensive modulation of systemic autoimmunity.
Zhang X; Ren X; Li G; Jiao C; Zhang L; Zhao S; Wang J; Han ZC; Li X
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3143-52. PubMed ID: 21296818
[TBL] [Abstract][Full Text] [Related]
4. Enhanced immunosuppressive capability of mesenchymal stem cell-derived small extracellular vesicles with high expression of CD73 in experimental autoimmune uveitis.
Duan Y; Chen X; Shao H; Li Y; Zhang Z; Li H; Zhao C; Xiao H; Wang J; Zhang X
Stem Cell Res Ther; 2024 May; 15(1):149. PubMed ID: 38783393
[TBL] [Abstract][Full Text] [Related]
5. Contribution of CD4+CD25+ T cells to the regression phase of experimental autoimmune uveoretinitis.
Sun M; Yang P; Du L; Zhou H; Ren X; Kijlstra A
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):383-9. PubMed ID: 19696173
[TBL] [Abstract][Full Text] [Related]
6. Treatment With FoxP3+ Antigen-Experienced T Regulatory Cells Arrests Progressive Retinal Damage in a Spontaneous Model of Uveitis.
Liu YH; Mölzer C; Makinen K; Kamoi K; Corbett CLC; Klaska IP; Reid DM; Wilson HM; Kuffová L; Cornall RJ; Forrester JV
Front Immunol; 2020; 11():2071. PubMed ID: 33013877
[TBL] [Abstract][Full Text] [Related]
7. Combination cell therapy using mesenchymal stem cells and regulatory T-cells provides a synergistic immunomodulatory effect associated with reciprocal regulation of TH1/TH2 and th17/treg cells in a murine acute graft-versus-host disease model.
Lim JY; Park MJ; Im KI; Kim N; Jeon EJ; Kim EJ; Cho ML; Cho SG
Cell Transplant; 2014 Apr; 23(6):703-14. PubMed ID: 23452894
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Noninfectious Uveitis Using Intravenous Administration of Collagen II-Specific Type 1 Regulatory T Cells.
Asnagli H; Jacquin M; Belmonte N; Gertner-Dardenne J; Hubert MF; Sales A; Fall PB; Ginet C; Marchetti I; Ménard F; Lara G; Bobak N; Foussat A
Invest Ophthalmol Vis Sci; 2015 Oct; 56(11):6456-66. PubMed ID: 26447979
[TBL] [Abstract][Full Text] [Related]
9. Blockade of interleukin-6 signaling suppresses not only th17 but also interphotoreceptor retinoid binding protein-specific Th1 by promoting regulatory T cells in experimental autoimmune uveoretinitis.
Haruta H; Ohguro N; Fujimoto M; Hohki S; Terabe F; Serada S; Nomura S; Nishida K; Kishimoto T; Naka T
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3264-71. PubMed ID: 21330657
[TBL] [Abstract][Full Text] [Related]
10. Notch signalling suppresses regulatory T-cell function in murine experimental autoimmune uveitis.
Rong H; Shen H; Xu Y; Yang H
Immunology; 2016 Dec; 149(4):447-459. PubMed ID: 27564686
[TBL] [Abstract][Full Text] [Related]
11. The immunomodulatory effects of human mesenchymal stem cells on peripheral blood mononuclear cells in ALS patients.
Kwon MS; Noh MY; Oh KW; Cho KA; Kang BY; Kim KS; Kim YS; Kim SH
J Neurochem; 2014 Oct; 131(2):206-18. PubMed ID: 24995608
[TBL] [Abstract][Full Text] [Related]
12. CTLA4-Ig suppresses development of experimental autoimmune uveitis in the induction and effector phases: Comparison with blockade of interleukin-6.
Iwahashi C; Fujimoto M; Nomura S; Serada S; Nakai K; Ohguro N; Nishida K; Naka T
Exp Eye Res; 2015 Nov; 140():53-64. PubMed ID: 26297802
[TBL] [Abstract][Full Text] [Related]
13. ICOSL expression in human bone marrow-derived mesenchymal stem cells promotes induction of regulatory T cells.
Lee HJ; Kim SN; Jeon MS; Yi T; Song SU
Sci Rep; 2017 Mar; 7():44486. PubMed ID: 28290526
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic administration of bone marrow-derived mesenchymal stromal cells reduces airway inflammation without up-regulating Tregs in experimental asthma.
Kitoko JZ; de Castro LL; Nascimento AP; Abreu SC; Cruz FF; Arantes AC; Xisto DG; Martins MA; Morales MM; Rocco PRM; Olsen PC
Clin Exp Allergy; 2018 Feb; 48(2):205-216. PubMed ID: 29068567
[TBL] [Abstract][Full Text] [Related]
15. AS101 ameliorates experimental autoimmune uveitis by regulating Th1 and Th17 responses and inducing Treg cells.
Bing SJ; Shemesh I; Chong WP; Horai R; Jittayasothorn Y; Silver PB; Sredni B; Caspi RR
J Autoimmun; 2019 Jun; 100():52-61. PubMed ID: 30853312
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal Stem Cells Inhibited Dendritic Cells Via the Regulation of STAT1 and STAT6 Phosphorylation in Experimental Autoimmune Uveitis.
Dong L; Chen X; Shao H; Bai L; Li X; Zhang X
Curr Mol Med; 2018 Mar; 17(7):478-487. PubMed ID: 29424313
[TBL] [Abstract][Full Text] [Related]
17. Induction of CD4
Khosravi M; Bidmeshkipour A; Moravej A; Hojjat-Assari S; Naserian S; Karimi MH
Immunol Res; 2018 Feb; 66(1):207-218. PubMed ID: 29143918
[TBL] [Abstract][Full Text] [Related]
18. Induction of CD4
Khosravi M; Bidmeshkipour A; Cohen JL; Moravej A; Hojjat-Assari S; Naserian S; Karimi MH
Stem Cell Res Ther; 2018 Oct; 9(1):273. PubMed ID: 30359308
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cell effects on T-cell effector pathways.
Duffy MM; Ritter T; Ceredig R; Griffin MD
Stem Cell Res Ther; 2011 Aug; 2(4):34. PubMed ID: 21861858
[TBL] [Abstract][Full Text] [Related]
20. Ly6C
Ko JH; Lee HJ; Jeong HJ; Oh JY
Biochem Biophys Res Commun; 2017 Dec; 494(1-2):6-12. PubMed ID: 29056505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
